Samsung is proceeding with an investment in Averr BioTechnology (Averr Bio), a U.S.-based biotech company specializing in gene-editing technology. The move aims to explore high-growth new business ...

As South Korea increases its stakes on the “bioeconomy” as its next growth engine and as its “second semiconductor industry,” leading domestic biologic and biosimilar drug producers such as Samsung ...